Literature DB >> 8892891

Human recombinant antibody fragments neutralizing human immunodeficiency virus type 1 reverse transcriptase provide an experimental basis for the structural classification of the DNA polymerase family.

N Gargano1, S Biocca, A Bradbury, A Cattaneo.   

Abstract

We describe in this paper the binding and biochemical properties of two human antibody fragments directed against the human immunodeficiency virus type 1 reverse transcriptase (RT). These fragments were isolated from a synthetic combinatorial library of human Fab antibody fragments displayed on the surface of filamentous phage. The antibody fragments were selected by using recombinant heterodimeric human immunodeficiency virus type 1 RT purified from insect cells as a solid-phase selector. This procedure led to the isolation of two antibody fragments that completely neutralize the RNA-dependent DNA polymerase activity of RT at nanomolar concentrations. Both antibody fragments bind only to the enzymatically active form of the RT. The inhibitory activity of the anti-RT antibody fragments is competitive with respect to the template primer. The antibody fragments also neutralize the activities of RTs from avian and murine retroviruses and of DNA polymerases of prokaryotic origin as well as human DNA polymerase alpha. Thus, the antibody fragments selected and characterized in this study appear to recognize a structural fold that is common to the different DNA polymerases and necessary for their activity. The results provide an immunological experimental basis for a purely structural and evolutionary classification of the polymerase family.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8892891      PMCID: PMC190840     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

Review 1.  Site-directed mutagenesis of HIV reverse transcriptase to probe enzyme processivity and drug binding.

Authors:  W A Beard; S H Wilson
Journal:  Curr Opin Biotechnol       Date:  1994-08       Impact factor: 9.740

2.  High resolution structures of HIV-1 RT from four RT-inhibitor complexes.

Authors:  J Ren; R Esnouf; E Garman; D Somers; C Ross; I Kirby; J Keeling; G Darby; Y Jones; D Stuart
Journal:  Nat Struct Biol       Date:  1995-04

3.  An attempt to unify the structure of polymerases.

Authors:  M Delarue; O Poch; N Tordo; D Moras; P Argos
Journal:  Protein Eng       Date:  1990-05

Review 4.  Intracellular antibodies: development and therapeutic potential.

Authors:  J H Richardson; W A Marasco
Journal:  Trends Biotechnol       Date:  1995-08       Impact factor: 19.536

Review 5.  Making antibodies by phage display technology.

Authors:  G Winter; A D Griffiths; R E Hawkins; H R Hoogenboom
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

6.  Catalytic properties of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2.

Authors:  A Hizi; R Tal; M Shaharabany; S Loya
Journal:  J Biol Chem       Date:  1991-04-05       Impact factor: 5.157

7.  Expression and targeting of intracellular antibodies in mammalian cells.

Authors:  S Biocca; M S Neuberger; A Cattaneo
Journal:  EMBO J       Date:  1990-01       Impact factor: 11.598

8.  Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody.

Authors:  L Duan; O Bagasra; M A Laughlin; J W Oakes; R J Pomerantz
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

9.  By-passing immunization. Human antibodies from V-gene libraries displayed on phage.

Authors:  J D Marks; H R Hoogenboom; T P Bonnert; J McCafferty; A D Griffiths; G Winter
Journal:  J Mol Biol       Date:  1991-12-05       Impact factor: 5.469

Review 10.  Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance.

Authors:  C Tantillo; J Ding; A Jacobo-Molina; R G Nanni; P L Boyer; S H Hughes; R Pauwels; K Andries; P A Janssen; E Arnold
Journal:  J Mol Biol       Date:  1994-10-28       Impact factor: 5.469

View more
  6 in total

1.  Monoclonal antibodies against the minimal DNA-binding domain in the carboxyl-terminal region of human immunodeficiency virus type 1 integrase.

Authors:  T Ishikawa; N Okui; N Kobayashi; R Sakuma; T Kitamura; Y Kitamura
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Design and intracellular activity of a human single-chain antibody to human immunodeficiency virus type 1 conserved gp41 epitope.

Authors:  I Legastelois; C Desgranges
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  Properties of monoclonal antibodies directed against hepatitis B virus polymerase protein.

Authors:  J zu Putlitz; R E Lanford; R I Carlson; L Notvall; S M de la Monte; J R Wands
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

Review 4.  Phages and HIV-1: from display to interplay.

Authors:  Sylvie Delhalle; Jean-Claude Schmit; Andy Chevigné
Journal:  Int J Mol Sci       Date:  2012-04-13       Impact factor: 6.208

5.  Bacterial Inner-membrane Display for Screening a Library of Antibody Fragments.

Authors:  Parisa Moghaddam-Taaheri; Svetlana P Ikonomova; Zifan Gong; Janna Q Wisniewski; Amy J Karlsson
Journal:  J Vis Exp       Date:  2016-10-15       Impact factor: 1.355

Review 6.  Intracellular antibodies for proteomics.

Authors:  Michela Visintin; Giovanni Antonio Meli; Isabella Cannistraci; Antonino Cattaneo
Journal:  J Immunol Methods       Date:  2004-07       Impact factor: 2.303

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.